# Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD

> **NCT07523880** · — · RECRUITING · sponsor: **Xueyan Zhao** · enrollment: 12154 (estimated)

## Conditions studied

- Thrombosis
- Bleeding
- Coronary Artery Disease (CAD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07523880
- **Lead sponsor:** Xueyan Zhao
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2029-01
- **Final completion:** 2029-07
- **Target enrollment:** 12154 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07523880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07523880, "Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07523880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*